SEARCH

SEARCH BY CITATION

References

  • 1
    Ogden CL, Carroll MD, Kit BK, et al. Prevalence of obesity in the United States, 2009-2020. NCHS Data Brief 2012; 82: 1-8. EL 3, SS.
  • 2
    Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010; 363: 2211-9. Erratum in: N Engl J Med 2011; 365: 869. EL 3, SS.
  • 3
    Mechanick JI, Garber AJ, Handelsman Y, et al. American Association of Clinical Endocrinologists (AACE) position paper on obesity and obesity medicine. Endocr Pract 2012; 18: 642-8. EL 4, NE position.
  • 4
    Ryan DH, Johnson WD, Myers VH, et al. Nonsurgical weight loss for extreme obesity in primary care settings: results of the Louisiana Obese Subjects Study. Arch Intern Med 2010; 170: 146-54. EL 1, RCT.
  • 5
    Livingston EH. The incidence of bariatric surgery has plateaued in the U.S. Am J Surg 2010; 200: 378-85. EL 3, SS.
  • 6
    Fact Sheet. Metabolic & Bariatric Surgery. American Society for Metabolic & Bariatric Surgery. Available at: http://www.asbs.org/Newsite07/media/asmbs_fs_surgery.pdf. Accessed August 8, 2009. EL 3, SS.
  • 7
    Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists, The Obesity Society, and the American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract 2008; 14:( Suppl 1): 1-83. EL 4, CPG.
  • 8
    American Society for Metabolic & Bariatric Surgery. Updated position statement on sleeve gastrectomy as a bariatric procedure, revised 10/28/2011. Available at: http://www.thinnertimesforum.com/topic/65864-october-2011-sleeve-gastrectomy-position-statement-from-asmbs/. Accessed April 22, 2012. EL 4, NE position.
  • 9
    Hutter MM, Schirmer BD, Jones DB, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg 2011; 254: 410-20. EL 2, PCS.
  • 10
    O'Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med 2006; 144: 625-33. EL 1, RCT.
  • 11
    Sultan S, Parikh M, Youn H, et al. Early U.S. outcomes after laparoscopic adjustable gastric banding in patients with a body mass index less than 35kg/m2. Surg Endosc 2009; 23: 1569-73. EL 2, PCS.
  • 12
    Parikh M, Duncombe J, Fielding GA. Laparoscopic adjustable gastric banding for patients with body mass index of ≤35 kg/m2. Surg Obes Relat Dis 2006; 2: 518-22. EL 2, PCS.
  • 13
    Angrisani L, Favretti F, Furbetta F, et al. Italian group for Lap-Band system: results of multicenter study on patients with BMI ≤35kg/m2. Obes Surg 2004; 14: 415-8. EL 3, SS.
  • 14
    U.S. Food and Drug Administration. FDA expands use of banding system for weight loss. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm245617.htm. Accessed April 22, 2012. EL 4, NE position.
  • 15
    Dixon JB, Zimmet P, Alberti KG. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med 2011; 28: 628-42. EL 4, NE position.
  • 16
    Sjöström L, Lindroos AK, Peltonen M. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-93. EL 2, PCS.
  • 17
    Adams TD, Davidson LE, Litwin SE, et al. Health benefits of gastric bypass surgery after 6 years. JAMA 2012; 308: 1122-31. EL 2, PCS.
  • 18
    NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 1991; 115: 956-61. EL 4, NE consensus.
  • 19
    Tsai WS. Bariatric Surgery in Adolescents: recent national trends in use and in-hospital outcome. Arch Pediatr Adolesc Med 2007; 161: 217-21. EL 3, SS.
  • 20
    Nguyen NT, Karipineni F, Masoomi H. Increasing utilization of laparoscopic gastric banding in the adolescent: data from academic medical centers, 2002-2009. Am Surg 2011; 11: 1510-4. EL 3, SS.
  • 21
    Livingston EH, Huerta S, Arthur D. Male gender is a predictor of morbidity and age a predictor of mortality for patients undergoing gastric bypass surgery. Ann Surg 2002; 236: 576-82. EL 3, SS.
  • 22
    Dorman RB, Abraham AA, Al-Refaie WB. Bariatric Surgery Outcomes in the ELderly: An ACS NSQIP Study. J Gastrointest Surg 2012; 16: 35-44. EL 3, SS.
  • 23
    DeMaria EJ, Murr M, Byrne TK. Validation of the obesity surgery mortality risk score in a multicenter study proves it stratifies mortality risk in patients undergoing gastric bypass for morbid obesity. Ann Surg 2007; 246: 578-82. EL 3, SS.
  • 24
    DeMaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: Proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis 2007; 3: 134-40. EL 3, SS.
  • 25
    The Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Perioperative Safety in the Longitudinal Assessment of Bariatric Surgery. N Engl J Med 2009; 361: 445-54. EL 2, PCS.
  • 26
    Sjöström L, Peltonen M, Jacobson P. Bariatric surgery and long- term cardiovascular events. JAMA 2012; 307: 56-65. EL 2, PCS.
  • 27
    Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357: 753-61. EL 2, RCCS.
  • 28
    Winters BD, Gurses AP, Lehmann H, et al. Clinical review: checklists—translating evidence into practice. Crit Care 2009; 13: 210-20. EL 4, review.
  • 29
    Agency for Healthcare research and Quality (AHRQ). National Guideline Clearinghouse. Available at: http://www.guideline.gov/content.aspx?id=13022&search=bariatricþaace. Accessed December 29, 2011. EL 4, NE cpg.
  • 30
    Mechanick JI, Camacho PM, Cobin RH, et al. American Association of Clinical Endocrinologists protocol for standardized production of clinical practice guidelines—2010 update. Endocr Pract 2010; 16: 270-83. EL 4, NE cpg.
  • 31
    Pontiroli AEW, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg 2011; 253: 484-7.
  • 32
    Buchwald H, Rudser KD, Williams SE, et al. Overall mortality, incremental life expectancy, and cause of death at 25 years in the program on the surgical control of the hyperlipidemias. Ann Surg 2010; 251: 1034-40. EL 1; RCT.
  • 33
    Padwal R, Klarenbach S, Wiebe N, et al. Bariatric surgery: a systematic review and network meta-analysis of randomized trials. Obes Rev 2011; 12: 602-21. EL 1; MRCT.
  • 34
    Garb J, Welch G, Zagarins S, et al. Bariatric surgery for the treatment of morbid obesity: a meta-analysis of weight loss outcomes for laparoscopic adjustable gastric banding and laparoscopic gastric bypass. Obes Surg 2009; 19: 1447-55. EL 1; MRCT.
  • 35
    Valezi AC, Mali Junior J, de Menezes MA, et al. Weight loss outcome after silastic ring Roux-en Y gastric by-pass: 8 years of follow-up. Obes Surg 2010; 20: 1491-5. EL 2; PCS.
  • 36
    Toouli J, Kow L, Ramos AC, et al. International multicenter study of safety and effectiveness of Swedish Adjustable Gastric Band in 1-, 3-, and 5-year follow-up cohorts. Surg Obes Relat Dis 2009; 5: 598-609. EL 2; PCS.
  • 37
    Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systemic review and meta-analysis. Am J Med 2009; 122: 248-56. EL 1; MRCT.
  • 38
    Hofsø D, Nordstrand N, Johnson LK, et al. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol 2010; 163: 735-45. EL 1; RCT.
  • 39
    Schauer PR, Kashyap S, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese diabetic patients. N Engl J Med 2012; 366: 1567-76. EL 1; RCT (nonblinded, nongeneralizable).
  • 40
    Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366: 1577-85. EL 1; RCT (nonblinded, nongeneralizable).
  • 41
    Hofsø D, Jenssen T, Bollerslev J, et al. Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol 2011; 164: 231-8. EL 1; RCT.
  • 42
    Lumachi F, Marzano B, Fanti G, et al. Hypoxemia and hypoventilation syndrome improvement after laparoscopic bariatric surgery in patients with morbid obesity. In Vivo 2010; 24: 329-31. EL 3; PCS (small sample size).
  • 43
    Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev 2012; 13: 275-86. EL 2, MNRCT.
  • 44
    Pories WJ, Dohm LG, Mansfield CJ. Beyond the BMI: the search for better guidelines for bariatric surgery. Obesity 2010; 18: 865-71. EL 4, NE opinion.
  • 45
    De Lorenzo A, Bianchi A, Maroni P. et al. Adiposity rather than BMI determines metabolic risk. Int J Cardiol Epub 2011 Nov 14. EL 3, CSS.
  • 46
    Katzmarzyk PT, Bray GA, Greenway FL, et al. Ethnic-specific BMI and Waist circumference thresholds. Obesity 2011; 19: 1272-8. EL 3, SS.
  • 47
    Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes (Lond) 2009; 33: 289-95. EL 4; NE theory.
  • 48
    Flum DR, Belle SH, King WC, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009; 361: 445-54. EL 2, PCS (large prospective cohort).
  • 49
    Nguyen NT, Masoomi H, Laugenour K, et al. Predictive factors of mortality in bariatric surgery: data from the Nationwide Inpatient Sample. Surgery 2011; 150: 347-51. EL 3, SS (large database).
  • 50
    Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes. JAMA 2008; 299: 316-23. EL 2; RCT (nonblinded).
  • 51
    Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs. sleeve gastrectomy for type 2 diabetes mellitus. Arch Surg 2011; 146: 143-8. EL 1; RCT.
  • 52
    Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI >35 and <35. J Gastrointest Surg 2008; 12: 945-52. EL 2; PCS.
  • 53
    Cohen RV, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 2012; 35: 1420-8. EL 2; PCS.
  • 54
    Choi J, Digiorgi M, Milone L, et al. Outcomes of laparoscopic adjustable gastric banding in patients with low body mass index. Surg Obes Relat Dis 2010; 6: 367-71. EL 2; PCS.
  • 55
    Serrot FJ, Dorman RB, Miller CJ, et al. Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index <35 kg/m2. Surgery 2011; 150: 684-91. EL 3; SS.
  • 56
    Fried M, Ribaric G, Buchwald JN, et al. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies. Obes Surg 2010; 20: 776-90. EL 4, NE review and analysis.
  • 57
    Lee WJ, Chong K, Chen CY, et al. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2. Obes Surg 2011; 21: 889-95. EL 2; PCS.
  • 58
    Demaria EJ, Winegar DA, Pate VW, et al. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database. Ann Surg 2010; 252: 559-66. EL 3; SS.
  • 59
    Lee WJ, Ser KH, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery 2010; 147: 664-9. EL 2; PCS.
  • 60
    Geloneze B, Geloneze SR, Fiori C, et al. Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion. Obes Surg 2009; 19: 1077-83. EL 2; NRCT.
  • 61
    Ramos AC, Galvão Neto MP, et al. Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI <30 kg/m2 (LBMI). Obes Surg 2009; 19: 307-12. EL 2; PCS.
  • 62
    Li Q, Chen L, Yang Z, et al. Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index <35 kg/m2. Diabetes Obes Metab 2012; 14: 262-70. EL 2; MNRCT.
  • 63
    Huang CK, Shabbir A, Lo CH, et al. Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25–35. Obes Surg 2011; 21: 1344-9. EL 2, PCS.
  • 64
    Shah SS, Todkar JS, Shah PS, et al. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m2. Surg Obes Relat Dis 2010; 6: 332-8. EL 2, PCS.
  • 65
    Blakemore AI, Froguel P. Investigation of Mendelian forms of obesity holds out the prospect of personalized medicine. Ann NY Acad Sci 2010; 1214: 180-9. EL 4, review.
  • 66
    Reoch J, Mottillo S, Shimony A, et al. Safety of laparoscopic vs open bariatric surgery: a systematic review and meta-analysis. Arch Surg 2011; 146: 1314-22. EL 1, MRCT.
  • 67
    Korner J, Inabnet W, Febres G, et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) 2009; 33: 786-95. EL 2, PCS.
  • 68
    Laferrere B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008; 93: 2479-85. EL 2, NRCT.
  • 69
    Bose M, Teixeira J, Olivan B, et al. Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. J Diabetes 2010; 2: 47-55. EL 2, PCS.
  • 70
    Vidal J, Ibarzabal A, Romero F, et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 2008; 18: 1077-82. EL 2, NRCT.
  • 71
    Schulman AP, del Genio F, Sinha N, Rubino F. “Metabolic” surgery for treatment of type 2 diabetes mellitus. Endocr Pract 2009; 15: 624-31. EL 4, NE Review.
  • 72
    Leslie DB, Dorman RB, Serrot FJ, et al. Efficacy of the Roux-en-Y gastric bypass compared to medically managed controls in meeting the American Diabetes Association composite end point goals for management of type 2 diabetes mellitus. Obes Surg 2012; 22: 367-74. EL 3, SS.
  • 73
    Carlsson LM, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 2012; 367: 695-704. EL 2, PCS.
  • 74
    Arterburn DE, Bogart A, Sherwood NE, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg 2013; 23: 93-102. EL 3, SS.
  • 75
    Laferrere B. Effect of gastric bypass surgery on the incretins. Diabetes Metab 2009; 35: 513-7. EL 2, NRCT.
  • 76
    Kashyap SR, Daud S, Kelly KR, et al. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) 2009; 34: 462-71. EL 2, NRCT.
  • 77
    Cummings DE. Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes (Lond) 2009; 33: ( Suppl 1): S33-40. EL 4, NE opinion.
  • 78
    Peterli R, Wolnerhanssen B, Peters T, et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 2009; 250: 234-41. EL 1, RCT (small sample size).
  • 79
    Mingrone G, Castagneto-Gissey L. Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab 2009; 35: 518-23. EL 4, NE review.
  • 80
    Briatore L, Salani B, Andraghetti G, et al. Beta-cell function improvement after biliopancreatic diversion in subjects with type 2 diabetes and morbid obesity. Obesity (Silver Spring); 18: 932-6. EL 2, PCS.
  • 81
    Briatore L, Salani B, Andraghetti G, et al. Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion. Obesity (Silver Spring) 2008; 16: 77-81. EL 2, PCS.
  • 82
    Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008; 247: 401-7. EL 1, RCT (small sample size).
  • 83
    Basso N, Capoccia D, Rizzello M, et al. First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis. Surg Endosc 2011; 25: 3540-50. EL 2, PCS.
  • 84
    Valderas JP, Irribarra V, Rubio L, et al. Effects of sleeve gastrectomy and medical treatment for obesity on glucagon-like peptide 1 levels and glucose homeostasis in non-diabetic subjects. Obes Surg 2011; 21: 902-9. EL 2, NRCT.
  • 85
    Rubino F, Kaplan LM, Schauer PR, Cummings DE. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg 2010; 251: 399-405. EL 4, NE consensus.
  • 86
    Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 2010; 61: 393-411. EL 4, NE review.
  • 87
    Laferrere B. Diabetes remission after bariatric surgery: is it just the incretins? Int J Obes (Lond) 2011; 35:( Suppl 3): S22-5. EL 4, NE review.
  • 88
    Lee WJ, Chen CY, Chong K, Lee YC, Chen SC, Lee SD. Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis 2011; 7: 683-90. EL 1, RCT (follow-up study; small sample size).
  • 89
    Behrens C, Tang BQ, Amson BJ. Early results of a Canadian laparoscopic sleeve gastrectomy experience. Can J Surg 2011; 54: 138-43. EL 3, SS.
  • 90
    Bellanger DE, Greenway FL. Laparoscopic sleeve gastrectomy, 529 cases without a leak: short-term results and technical considerations. Obes Surg 2011; 21: 146-50. EL 3, SS.
  • 91
    Bobowicz M, Lehmann A, Orlowski M, Lech P, Michalik M. Preliminary Outcomes 1 Year after Laparoscopic Sleeve Gastrectomy Based on Bariatric Analysis and Reporting Outcome System (BAROS). Obes Surg 2011; 21: 1843-8. EL 2, PCS.
  • 92
    Breznikar B, Dinevski D. Bariatric surgery for morbid obesity: pre- operative assessment, surgical techniques and postoperative monitoring. J Int Med Res 2009; 37: 1632-45. EL 3, SS.
  • 93
    Chowbey PK, Dhawan K, Khullar R, et al. Laparoscopic sleeve gastrectomy: an Indian experience-surgical technique and early results. Obes Surg 2010; 20: 1340-7. EL 3, SS.
  • 94
    Gadiot RP, Biter LU, Zengerink HJ, et al. Laparoscopic sleeve gastrectomy with an extensive posterior mobilization: Technique and Preliminary Results. Obes Surg 2012; 22: 320-9. EL 3, SS.
  • 95
    Kiriakopoulos A, Varounis C, Tsakayannis D, Linos D. Laparoscopic sleeve gastrectomy in morbidly obese patients. Technique and short term results. Hormones (Athens) 2009; 8: 138-43. EL 2, PCS.
  • 96
    Lewis CE, Dhanasopon A, Dutson EP, Mehran A. Early experience with laparoscopic sleeve gastrectomy as a single-stage bariatric procedure. Am Surg 2009; 75: 945-9. EL 3, SS.
  • 97
    Magee CJ, Barry J, Arumugasamy M, Javed S, Macadam R, Kerrigan DD. Laparoscopic sleeve gastrectomy for high-risk patients: weight loss and comorbidity improvement–short-term results. Obes Surg 2011; 21: 547-50. EL 2, PCS.
  • 98
    Menenakos E, Stamou KM, Albanopoulos K, Papailiou J, Theodorou D, Leandros E. Laparoscopic sleeve gastrectomy performed with intent to treat morbid obesity: a prospective single- center study of 261 patients with a median follow-up of 1 year. Obes Surg 2010; 20: 276-82. EL 2, PCS.
  • 99
    Ramalingam G, Anton CK. Our 1-Year Experience in Laparoscopic Sleeve Gastrectomy. Obes Surg 2011; 21: 1828-33. EL 3, SS.
  • 100
    Rice RD, Simon TE, Seery JM, Frizzi JD, Husain FA, Choi YU. Laparoscopic sleeve gastrectomy: outcomes at a military training center. Am Surg 2010; 76: 835-40. EL 3, SS.
  • 101
    Sammour T, Hill AG, Singh P, Ranasinghe A, Babor R, Rahman H. Laparoscopic sleeve gastrectomy as a single-stage bariatric procedure. Obes Surg 2010; 20: 271-5. EL 3, SS.
  • 102
    Stroh C, Birk D, Flade-Kuthe R, et al. Status of bariatric surgery in Germany–results of the nationwide survey on bariatric surgery 2005-2007. Obes Facts 2009; 2:( Suppl 1): 2-7. EL 2, PCS.
  • 103
    Benaiges D, Goday A, Ramon JM, Hernandez E, Pera M, Cano JF. Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-up. Surg Obes Relat Dis 2011; 7: 575-80. EL 2, PCS.
  • 104
    Benedix F, Westphal S, Patschke R, et al. Weight loss and changes in salivary ghrelin and adiponectin: comparison between sleeve gastrectomy and Roux-en-Y gastric bypass and gastric banding. Obes Surg 2011; 21: 616-24. EL 2, NRCT.
  • 105
    Chouillard EK, Karaa A, Elkhoury M, Greco VJ. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity: case-control study. Surg Obes Relat Dis 2011; 7: 500-5. EL 2, RCCS.
  • 106
    Iannelli A, Anty R, Schneck AS, Tran A, Gugenheim J. Inflammation, insulin resistance, lipid disturbances, anthropometrics, and metabolic syndrome in morbidly obese patients: a case control study comparing laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. Surgery 2011; 149: 364-70. EL 2, RCCS.
  • 107
    Leyba JL, Aulestia SN, Llopis SN. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the treatment of morbid obesity. A prospective study of 117 patients. Obes Surg 2011; 21: 212-6. EL 2, PCS.
  • 108
    Nocca D, Guillaume F, Noel P, et al. Impact of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on Hb A1c blood level and pharmacological treatment of type 2 diabetes mellitus in severe or morbidly obese patients. Results of a multicenter prospective study at 1 year. Obes Surg 2011; 21: 738-43. EL 2, PCS.
  • 109
    Abbatini F, Rizzello M, Casella G, et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc 2010; 24: 1005-10. EL 3, SS.
  • 110
    de Gordejuela AG, Pujol Gebelli J, Garcia NV, Alsina EF, Medayo LS, Masdevall Noguera C. Is sleeve gastrectomy as effective as gastric bypass for remission of type 2 diabetes in morbidly obese patients? Surg Obes Relat Dis 2011; 7: 506-9EL 3, SS.
  • 111
    Garrido-Sanchez L, Murri M, Rivas-Becerra J, et al. Bypass of the duodenum improves insulin resistance much more rapidly than sleeve gastrectomy. Surg Obes Relat Dis 2012; 8: 145-50. EL 2, NRCT.
  • 112
    Lakdawala MA, Bhasker A, Mulchandani D, Goel S, Jain S. Comparison between the results of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass in the Indian population: a retrospective 1 year study. Obes Surg 2010; 20: 1-6. EL 2, RCCS.
  • 113
    Marantos G, Daskalakis M, Karkavitsas N, Matalliotakis I, Papadakis JA, Melissas J. Changes in metabolic profile and adipoinsular axis in morbidly obese premenopausal females treated with restrictive bariatric surgery. World J Surg 2011; 35: 2022-30. EL 2, NRCT.
  • 114
    Omana JJ, Nguyen SQ, Herron D, Kini S. Comparison of comorbidity resolution and improvement between laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding. Surg Endosc 2010; 24: 2513-7. EL 3, SS.
  • 115
    Topart P, Becouarn G, Ritz P. Comparative early outcomes of three laparoscopic bariatric procedures: sleeve gastrectomy, Roux-en-Y gastric bypass, and biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis 2012; 8: 250-4. EL 3, SS.
  • 116
    Kehagias I, Karamanakos SN, Argentou M, Kalfarentzos F Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI <50 kg/m2. Obes Surg 2011; 21: 1650-6. EL 1, RCT.
  • 117
    Himpens J, Dapri G, Cadiere GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 2006; 16: 1450-6. EL 1, RCT.
  • 118
    Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 2011; 146: 143-8. EL 1, RCT.
  • 119
    Woelnerhanssen B, Peterli R, Steinert RE, Peters T, Borbely Y, Beglinger C. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy-a prospective randomized trial. Surg Obes Relat Dis 2011; 7: 561-8. EL 1, RCT (small sample size).
  • 120
    Brethauer SA, Hammel JP, Schauer PR. Systematic review of sleeve gastrectomy as staging and primary bariatric procedure. Surg Obes Relat Dis 2009; 5: 469-75. EL 2, MNRCT.
  • 121
    Gill RS, Birch DW, Shi X, et al. Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis 2010; 6: 707-13. EL 2, MNRCT.
  • 122
    Hutter MM, Schirmer BD, Jones DB, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg 2011; 254: 410-20. discussion 20-2. EL 3, SS.
  • 123
    Birkmeyer NJ, Dimick JB, Share D, et al. Hospital complication rates with bariatric surgery in Michigan. JAMA 2010; 304: 435-42. EL 3, SS.
  • 124
    Bohdjalian A, Langer FB, Shakeri-Leidenmuhler S, et al. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg 2010; 20: 535-40. EL 2, PCS.
  • 125
    D'Hondt M, Vanneste S, Pottel H, Devriendt D, Van Rooy F, Vansteenkiste F. Laparoscopic sleeve gastrectomy as a single-stage procedure for the treatment of morbid obesity and the resulting quality of life, resolution of comorbidities, food tolerance, and 6-year weight loss. Surg Endosc 2011; 25: 2498-504. EL 3, SS.
  • 126
    Himpens J, Dobbeleir J, Peeters G. Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg 2010; 252: 319-24. EL 3, SS.
  • 127
    Sarela AI, Dexter SP, O'Kane M, Menon A, McMahon MJ. Long- term follow-up after laparoscopic sleeve gastrectomy: 8-9-year results. Surg Obes Relat Dis 2012; 8: 679-84. EL 3, SS.
  • 128
    Weiner RA, Weiner S, Pomhoff I, Jacobi C, Makarewicz W, Weigand G. Laparoscopic sleeve gastrectomy—influence of sleeve size and resected gastric volume. Obes Surg 2007; 17: 1297-305. EL 2, PCS.
  • 129
    Shi X, Karmali S, Sharma AM, et al. A review of laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg 2010; 20: 1171-7. EL 2, MNRCT.
  • 130
    Talebpour M, Amoli BS. Laparoscopic total gastric vertical plication in morbid obesity. J Laparoendosc Adv Surg Tech A 2007; 17: 793-8. EL 2, PCS.
  • 131
    Skrekas G, Antiochos K, Stafyla VK. Laparoscopic gastric greater curvature plication: results and complications in a series of 135 patients. Obes Surg 2011; 21: 1657-63. EL 2, PCS.
  • 132
    Ramos A, Galvao Neto M, Galvao M, Evangelista LF, Campos JM, Ferraz A. Laparoscopic greater curvature plication: initial results of an alternative restrictive bariatric procedure. Obes Surg 2010; 20: 913-8. EL 2, PCS.
  • 133
    Brethauer SA, Harris JL, Kroh M, et al. Laparoscopic gastric plication for treatment of severe obesity. Surg Obes Relat Dis 2011; 7: 15-22. EL 2, PCS.
  • 134
    Gould J, Ellsmere J, Fanelli R, et al. Panel report: best practices for the surgical treatment of obesity. Surg Endosc 2011; 25: 1730-40. EL 3, NE consensus.
  • 135
    Eaton L, Walsh C, Magnuson T, et al. On-line bariatric surgery information session as effective as in-person information session. Surg Obes Relat Dis 2012; 8: 225-9. EL 2, PCS.
  • 136
    Sabin J, Fanelli R, Flaherty H, et al. Best practice guidelines on informed consent for weight loss surgery patients. Obes Res 2005; 13: 250-3. EL 4, NE technical review.
  • 137
    Wee CC, Pratt JS, Fanelli R, et al. Best practice updates for informed consent and patient education in weight loss surgery. Obesity 2009; 17: 885-8. EL 4, NE technical review.
  • 138
    Raper SE, Sarwer DB. Informed consent issues in the conduct of bariatric surgery. Surg Obes Relat Dis 2008; 4: 60-8. EL 4, NE review.
  • 139
    Eggers C, Obliers R, Koerfer A, et al. A multimedia tool for the informed consent of patients prior to gastric banding. Obesity 2007; 15: 2866-73. EL 2, NRCT.
  • 140
    Heinberg LJ, Keating K, Simonelli L. Discrepancy between ideal and realistic goal weights in three bariatric procedures: who is likely to be unrealistic? Obes Surg 2010; 20: 148-53EL 2, PCS.
  • 141
    Kaly P, Orellana S, Torrella T, et al. Unrealistic weight loss expectations in candidates for bariatric surgery. Surg Obes Rel Dis 2008; 4: 6-10. EL 3, SS.
  • 142
    White MA, Masheb RM, Rothschild BS, et al. Do patients' unrealistic weight goals have prognostic significance for bariatric surgery? Obes Surg 2007; 17: 74-81. EL 2, PCS.
  • 143
    Mosko JD, Nguyen GC. Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol 2011; 9: 897-901. EL 3, SS.
  • 144
    Geerts A, Darius T, Chapelle T, et al. The multicenter Belgian survey on liver transplantation for hepatocellular failure after bariatric surgery. Transplant Proc 2010; 42: 4395-8. EL 3, SS.
  • 145
    Fris RJ. Preoperative low energy diet diminishes liver size. Obes Surg 2004; 14: 1165-70. EL 2, PCS.
  • 146
    Edholm D, Kullberg J, Haenni A, et al. Preoperative 4-week low- calorie diet reduces liver volume and intrahepatic fat, and facilitates laparoscopic gastric bypass in morbidly obese. Obes Surg 2011; 21: 345-50. EL 2, PCS.
  • 147
    Nieuwnhove YV, Dambrauskas Z, Campillo-Soto A, et al. Preoperative very low-calorie diet and operative outcome after laparoscopic gastric bypass. Arch Surg 2011; 146: 1300-5. EL 1, RCT (multicenter, single-blinded).
  • 148
    Alvarado R, Alami RS, Hsu G, et al. The impact of preoperative weight loss in patients undergoing laparoscopic Roux-en-Y gastric bypass. Obes Surg 2005; 15: 1282-6. EL 3, SS.
  • 149
    Alami RS, Morton JM, Schuster R, et al. Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial. Surg Obes Rel Dis 2007; 3: 141-6. EL 1, RCT.
  • 150
    Frutos MD, Morales MD, Lujan J, et al. Intragastric balloon reduces liver volume in super-obese patients, facilitating subsequent laparoscopic gastric bypass. Obes Surg 2007; 17: 150-4. EL 2, PCS.
  • 151
    Collins J, McCloskey C, Titchner R, et al. Preoperative weight loss in high-risk superobese bariatric patients: a computed tomography- based analysis. Surg Obes Rel Dis 2011; 7: 480-5. EL 2, PCS.
  • 152
    Becouarn G, Topart P, Ritz P. Weight loss prior to bariatric surgery is not a pre-requisite of excess weight loss outcomes in obese patients. Obes Surg 2010; 20: 574-7. EL 3, SS.
  • 153
    Handelsman Y, Mechanick JI, Blonde L, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan. Endocr Practice 2011; 17:( Suppl 2): 1-52. EL 4, NE CPG.
  • 154
    Hall TC, Pellen MGC, Sedman PC, et al. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg 2010; 20: 1245-50. EL 2, PCS.
  • 155
    Martins-Filho ED, Camara-Neto JB, Ferraz AAB, et al. Evaluation of risk factors in superobese patients submitted to conventional Fobi- Capella surgery. Arq Gastroenterol 2008; 45: 3-10. EL 2, PCS.
  • 156
    Perna M, Romagnuolo J, Morgan K, et al. Preoperative hemoglobin A1c and postoperative glucose control in outcomes after gastric bypass for obesity. Surg Obes Relat Dis 2012; 6: 686-90. EL 3, SS.
  • 157
    Coupaye M, Sabate JM, Castel B, et al. Predictive factors of weight loss 1 year after laparoscopic gastric bypass in obese patients. Obes Surg 2010; 20: 1671-7. EL 2, PCS.
  • 158
    Lee W-J, Chong K, Ser K-H, et al. C-peptide predicts the remission of type 2 diabetes after bariatric surgery. Obes Surg 2012: 2: 293-8. EL 2, PCS.
  • 159
    Moulin de Moraes CM, Mancini MC, Edna de Melo M, et al. Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux- en-Y gastric bypass. Obes Surg 2005; 15: 1287-91. EL 2, PCS.
  • 160
    Raftopoulos Y, Gagne DJ, Papasavas P, et al. Improvement of hypothyroidism after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2004; 14: 509-13. EL 2, PCS.
  • 161
    Chikunguwo S, Brethauer S, Nirujogi V, et al. Influence of obesity and surgical weight loss on thyroid hormone levels. Surg Obes Relat Dis 2007; 3: 631-6. EL 3, SS.
  • 162
    Fierabracci P, Pinchera A, Marinelli S, et al. Prevalence of endocrine diseases in morbidly obese patients scheduled for bariatric surgery: beyond diabetes. Obes Surg 2011; 21: 54-60. EL 2, PCS.
  • 163
    Jankovic D, Wolf P, Anderwald C-H, et al. Prevalence of endocrine disorders in morbidly obese patients and the effects of bariatric surgery on endocrine and metabolic parameters. Obes Surg 2012; 22: 62-9. EL 3, SS.
  • 164
    Garber J, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 2012; 11: 1-207. EL 4, NE CPG.
  • 165
    Kashyap SR, Kiab DL, Baker AR, et al. Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort. Obesity 2009; 17: 1696-701. EL 2, PCS.
  • 166
    Jellinger PS, Smith DA, Mehta AE, et al. American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Practice 2012; 18: ( Suppl 1): 1-78. EL 4, NE CPG.
  • 167
    American College of Obstetricians and Gynecologists. ACOG Practice Bulletin no. 105: bariatric surgery and pregnancy. Obstet Gynecol 2009; 113: 1405-13. EL 4, position.
  • 168
    Kominiarek MA. Pregnancy after bariatric surgery. Obstet Gynecol Clin North Am 2010; 37: 305-20. EL 4, review.
  • 169
    Magdaleno R, Pereira BG, Chaim EA, et al. Pregnancy after bariatric surgery: a current view of maternal, obstetrical and perinatal challenges. Arch Gynecol Obstet 2012; 285: 559-66. EL 4, review.
  • 170
    Catheline JM, Bihan H, Le Quang T, et al. Preoperative cardiac and pulmonary assessment in bariatric surgery. Obes Surg 2008; 18: 271-7. EL 2, PCS.
  • 171
    Kwon S, Thompson R, Florence M, et al. b-blocker continua- tion after noncardiac surgery: a report from the surgical care and outcomes assessment program. Arch Surg 2012; 147: 467-73. EL 3, SS.
  • 172
    Rasmussen JJ, Fuller W.D, Ali M.R, Sleep apnea syndrome is significantly underdiagnosed in bariatric surgical patients. Surg Obes Relat Dis. 2012; 5: 569-73. EL 3, SS.
  • 173
    Kolotkin RL, LaMonte MJ, Walker JM, Cloward TV, Davidson LE, Crosby RD Predicting sleep apnea in bariatric surgery patients. Surg Obes Relat Dis 2011; 7: 605-610. EL 3, SS.
  • 174
    Daltro C, Gregorio PB, Alves E, et al. Prevalence and severity of sleep apnea in a group of morbidly obese patients. Obes Surg 2007; 17: 809-14. EL 3, CSS.
  • 175
    Palla A, Digiorgio M, Carpene N, et al. Sleep apnea in morbidly obese patients: prevalence and clinical predictivity. Respiration 2009; 78: 134-40. EL 3, SS.
  • 176
    Sareli AE, Cantor CR, Williams NN, et al. Obstructive sleep apnea in patients undergoing bariatric surgery—a tertiary center experience. Obes Surg 2009; 21: 316-27. EL 3, SS.
  • 177
    Lee YH, Johan A, Wong KK, et al. Prevalence and risk factors for obstructive sleep apnea in a multiethnic population of patients presenting for bariatric surgery in Singapore. Sleep Med 2009; 10: 226-32. EL 3, SS.
  • 178
    Dixon JB, Schachter LM, O'Brien PE. Predicting sleep apnea and excessive day sleepiness in the severely obese: indicators for polysomnography. Chest 2003; 123: 1134-41. EL 3, SS modeling.
  • 179
    Marshall NS, Wong KK, Liu PY, et al. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 2008; 31: 1079-85. EL 3, SS.
  • 180
    Flum DR, Belle SH, King WC, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009; 361: 445-54. EL 2, PCS.
  • 181
    Schumann R, Jones SB, Cooper B, et al. Update on best practice recommendations for anesthetic perioperative care and pain management in weight loss surgery, 2004-2007. Obesity (Silver Spring) 2009; 17: 889-94. EL 4, NE CPG.
  • 182
    Fritscher LG, Mottin CC, Canani S, et al. Obesity and obstructive sleep apnea-hypopnea syndrome: the impact of bariatric surgery. Obesity Surgery 2007; 17: 95-9. EL 4, review.
  • 183
    Felix EL, Kettelle J, Mobley E, Swartz D. Perforated marginal ulcers after laparoscopic gastric bypass. Surg Endosc 2008; 22: 2128-32. EL 3, SS.
  • 184
    Gupta PK, Gupta H, Kaushik M, et al. Predictors of pulmonary complications after bariatric surgery. Surg Obes Relat Dis 2012; 8: 574-81. EL 3, SS.
  • 185
    Gravante G, Araco A, Sorge R, et al. Wound infections in post- bariatric patients undergoing body contouring abdominoplasty: the role of smoking. Obes Surg 2007; 17: 1325-31. EL 3, SS.
  • 186
    Gravante G, Araco A, Sorge R, et al. Wound infections in body contouring mastopexy with breast reduction after laparoscopic adjustable gastric bandings: the role of smoking. Obes Surg 2008; 18: 721-7. EL 3, SS.
  • 187
    Myers K, Hajek P, Hinds C, et al. Stopping smoking shortly before surgery and postoperative complications: a systematic review and meta-analysis. Arch Intern Med 2011; 171: 983-9. EL 2, MNRCT.
  • 188
    Winegar DA, Sherif B, Pate V, DeMaria EJ. Venous thromboembolism after bariatric surgery performed by Bariatric Surgery Center of Excellence Participants: analysis of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis 2011; 7: 181-8. EL 3, SS.
  • 189
    Birkmeyer NJ, Share D, Baser O, et al. Preoperative placement of inferior vena cava filters and outcomes after gastric bypass surgery. Ann Surg 2010; 252: 313-8. EL 3, SS.
  • 190
    Al Akwaa A, El Zubier A, Al Shehri M. Pattern of liver function tests in morbidly obese Saudi patients undergoing bariatric surgery. Saudi J Gastroenterol 2011; 17: 252-5. EL 3, SS.
  • 191
    Kuper MA, Kratt T, Kramer KM, et al. Effort, safety, and findings of routine preoperative endoscopic evaluation of morbidly obese patients undergoing bariatric surgery. Surg Endosc 2010; 24: 1996-2001. EL 2, PCS.
  • 192
    Al-Akwaa AM. Prevalence of Helicobacter pylori infection in a group of morbidly obese Saudi patients undergoing bariatric surgery: a preliminary report. Saudi J Gastroenterol 2010; 16: 264-7. EL 3, SS.
  • 193
    Csendes A, Burgos AM, Smok G, et al. Endoscopic and histologic findings of the foregut in 426 patients with morbid obesity. Obes Surg 2007; 17: 28-34. EL 3, SS.
  • 194
    Erim T, Cruz-Correa MR, Szomstein S, et al. Prevalence of Helicobacter pylori seropositivity among patients undergoing bariatric surgery: a preliminary study. World J Surg 2008; 32: 2021-5. EL 3, SS.
  • 195
    de Moura Almeida A, Cotrim HP, Santos AS, et al. Preoperative upper gastrointestinal endoscopy in obese patients undergoing bariatric surgery: is it necessary? Surg Obes Relat Dis 2008: 144-9. EL 3, SS.
  • 196
    Hartin CW, ReMine DS, Lucktong TA. Preoperative bariatric screening and treatment of Helicobacter pylori. Surg Endosc 2009; 23: 2531-4. EL 3, SS.
  • 197
    Schirmer B, Erenoglu C, Miller A. Flexible endoscopy in the management of patients undergoing Roux-en-Y gastric bypass. Obes Surg 2002; 12: 634-8. EL 3, SS.
  • 198
    Yang CS, Lee WJ, Wang HH, et al. The influence of Helicobacter pylori infection on the development of gastric ulcer in symptomatic patients after bariatric surgery. Obes Surg 2006; 16: 735-9. EL 2, PCS.
  • 199
    Loewen M, Giovanni J, Barba C. Screening endoscopy before bariatric surgery: a series of 448 patients. Surg Obes Relat Dis 2008; 4: 709-12. EL 3, CCS.
  • 200
    Gould J. Prevalence of Helicobacter pylori infection among patients undergoing bariatric surgery: a preliminary study. World J Surg 2008; 32: 2026-7. EL 4, NE opinion.
  • 201
    Friedman JE, Dallal RM, Lord JL. Gout attacks occur frequently in postoperative gastric bypass patients. Surg Obes Relat Dis 2008; 4: 11-3. PMID: 18065292. EL 3, SS.
  • 202
    Pull CB. Current psychological assessment practices in obesity surgery programs: what to assess and why. Curr Opin Psychiatry 2010; 23: 30-6. EL 4, NE review.
  • 203
    Heinberg LJ, Ashton K, Windover A. Moving beyond dichotomous psychological evaluation: The Cleveland Clinic Behavioral Rating System for Weight Loss Surgery. Surg Obes Relat Dis 2010; 6: 185-90. EL 2, PCS.
  • 204
    Greenberg I, Sogg S, Perna FM. Behavioral and psychological care in weight loss surgery: Best practice update. Obesity 2009; 17: 880-4. EL 4, NE CPG.
  • 205
    Mahony D. Psychological assessments of bariatric surgery patients. Development, reliability, and exploratory factor analysis of the PsyBari. Obes Surg 2011; 21: 1395-406. EL 2, PCS.
  • 206
    Fabricatore AN, Crerand CE, Wadden TA, et al. How do mental health professionals evaluate candidates for bariatric surgery? Survey results. Obes Surg 2005; 15: 567-73. EL 3, SS.
  • 207
    Peacock J.C, Zizzi S.J, An assessment of patient behavioral requirements pre- and post-surgery at accredited weight loss surgical centers. Obes Surg 2011; 21: 1950-7. EL 3, SS.
  • 208
    Bauchowitz AU, Gonder-Frederick LA, Olbrisch ME, et al. Psychosocial evaluation of bariatric surgery candidates: a survey of present practices. Psychosom Med 2005; 67: 825-32. EL 3, SS.
  • 209
    Ambwani S, Boeka AG, Brown JD, et al. Socially desirable responding by bariatric surgery candidates during psychological assessment. Surg Obes Relat Dis. Epub 2011 Jul 18. EL 3, SS.
  • 210
    Mitchell JE, Steffen KJ. de Zwaan M, et al. Congruence between clinical and research-based psychiatric assessment in bariatric surgical candidates. Surg Obes Relat Dis 2010; 6: 628-34. EL 3, SS.
  • 211
    Kalarchian MA, Marcus MD, Levine MD, et al. Psychiatric disorders among bariatric surgery candidates: relationship to obesity and functional health status. Am J Psychiatry 2007; 164:( 2): 328-34. EL 3, SS.
  • 212
    King WC. Prevalence of Alcohol Use Disorders Before and After Bariatric Surgery. JAMA 2012; 307: 2515-25. EL 2, PCS.
  • 213
    Buffington CK. Alcohol use and health risks: survey results. Bariatric Times 2007; 4: 21-3. EL 3, SS.
  • 214
    Mitchell JE, Lancaster KL, Burgard MA, et al. Long-term follow-up of patients' status after gastric bypass. Obes Surg 2001; 11: 464-8. EL 2, PCS.
  • 215
    Ertelt TW, Mitchell JE, Lancaster K, et al. Alcohol abuse and dependence before and after bariatric surgery: a review of the literature and report of a new data set. Surg Obes Relat Dis 2008; 4: 647-50. EL 3, SS.
  • 216
    Saules KK, Wiedemann A, Ivezaj V, et al. Bariatric surgery history among substance abuse treatment patients: prevalence and associated features. Surg Obes Relat Dis 2010; 6: 615-21. EL 3, SS.
  • 217
    Clark MM, Balsiger BM, Sletten CD, et al. Psychosocial Factors and 2-Year Outcome Following Bariatric Surgery for Weight Loss. Obes Surg 2003; 13: 739-45. EL 2, PCS.
  • 218
    Heinberg LJ, Ashton K. History of substance abuse relates to improved postbariatric body mass index outcomes. Surg Obes Relat Dis 2010; 6: 417-21. EL 3, SS.
  • 219
    Klockhoff H, Naslund I, Jones AW. Faster absorption of ethanol and higher peak concentration in women after gastric bypass surgery. Br J Clin Pharm 2002; 54: 587-91. EL 2, NRCT.
  • 220
    Hagedorn JC, Encarnacion B, Brat GA, et al. Does gastric bypass alter alcohol metabolism? Surg Obes Rel Dis 2007; 3: 543-8. EL 2, PCS.
  • 221
    Woodard GA, Downey J, Hernandez-Boussard T, et al. Impaired alcohol metabolism after gastric bypass surgery: a case-crossover trial. J Am Coll Surg 2011; 212: 209-14. EL 2, PCS (crossover design).
  • 222
    Maluenda F, Csendes A, De Aretxabala X, et al. Alcohol absorption modification after a laparoscopic sleeve gastrectomy. Obes Surg 2010; 20: 744-8. EL 2, PCS.
  • 223
    Colles SL, Dixon JB, O'Brien PE. Grazing and loss of control related to eating: two high-risk factors following bariatric surgery. Obesity 2008; 16: 615-22. EL 2, PCS.
  • 224
    Kofman MD, Lent MR, Swencionis C. Maladaptive eating patterns, quality of life and weight outcomes following gastric bypass: Results on an internet survey. Obesity 2010; 18: 1938-43. EL 3, SS.
  • 225
    Kruseman M, Leimgruber A, Zumbach F, et al. Dietary, weight, and psychological changes among patients with obesity, 8 years after gastric bypass. J Am Diet Assoc 2010; 110: 527-34. EL 2, PCS.
  • 226
    deZwaan M, Mitchell JE, Howell LM, et al. Characteristics of morbidly obese patients before gastric bypass surgery. Compr Psychiatry 2003; 44: 428-34. EL 3, SS.
  • 227
    Hsu LK, Benotti PN, Dwyer J, et al. W. Nonsurgical factors that influence the outcome of bariatric surgery: A review. Psychosomatic Med 1998; 60: 338-46. EL 4, NE review.
  • 228
    Guisado Macias JA, Vaz Leal FJ. Psychopathological differences between morbidly obese binge eaters and non-binge eaters after bariatric surgery. Eat Weight Dis 2003; 8: 315-8. EL 3, CSS.
  • 229
    Sabbioni ME, Dickson MH, Eychmueller S, et al. Intermediate results of health related quality of life after vertical banded gastroplasty. Int J Obes Relat Metab Disord 2002; 26: 277-80. EL 2, PCS.
  • 230
    Toussi R, Fujioka K, Coleman KJ. Pre-and postsurgery behavioral compliance, patient health, and postbariatric surgical weight loss. Obesity 2009; 17: 966-1002. EL 3, SS.
  • 231
    Alger-Mayer S, Rosati C, Polimeni JM, et al. Preoperative binge eating status and gastric bypass surgery: A long-term outcome study. Obes Surg 2009; 19: 139-45. EL 2, PCS.
  • 232
    White MA, Mashed RM, Rothschild BS, et al. The prognostic significance of regular binge eating in extremely obese gastric bypass patients: 12-month postoperative outcomes. J Clin Psychiatry 2006; 67: 1928-35. EL 2, PCS.
  • 233
    Fujioka K, Yan E, Wang HJ, et al. Evaluating preoperative weight loss, binge eating disorder, and sexual abuse history on Roux-en Y gastric bypass outcome. Surg Obes Relat Dis 2008; 4: 137-43. EL 3, SS.
  • 234
    Sarwer DB, Wadden TA, Fabricatore AN. Psychosocial and behavioral aspects of bariatric surgery. Obes Res 2005; 13: 639-48. EL 4, NE review.
  • 235
    de Zwaan M, Hilbert A, Swan-Kremeier L, et al. Comprehensive interview assessment of eating behavior 18-35 months after gastric bypass surgery for morbid obesity. Surg Obes Relat Dis 2010; 6: 79-87. EL 3, SS.
  • 236
    White MA, Kalarchian M, Masheb RM, et al. Loss of control over eating predicts outcomes in bariatric surgery patients: a prospective, 24-month follow-up study. J Clin Psychiatry 2010; 71: 175-84. EL 2, PCS.
  • 237
    Sarwer DB, Dilks RJ, West-Smith L. Dietary intake and eating behavior after bariatric surgery: Threats to weight loss maintenance and strategies for success. Surg Obes Rel Dis 2011; 7: 644-51. EL 4, NE opinion.
  • 238
    Ashton K, Heinberg L, Windover A, et al. Positive response to binge eating intervention enhances postsurgical weight loss and adherence. Surg Obes Relat Dis 2011; 7: 315-20. EL 2, PCS.
  • 239
    Wadden TA, Faulconbridge LF, Jones-Corneille LR, et al. Binge eating disorder and the outcome of bariatric surgery at one year: A prospective, observational study. Obesity 2011; 19: 1220-8. EL 2, PCS.
  • 240
    de Luis DA, Pacheco D, Izaola O, et al. Micronutrient status in morbidly obese women before bariatric surgery. Surg Obes Relat Dis Epub 2011 Sep 29. EL 3, SS.
  • 241
    Schweiger C, Weiss R, Berry E, et al. Nutritional deficiencies in bariatric surgery candidates. Obes Surg 2010; 20: 193-7. EL 3, SS.
  • 242
    Ernst B, Thurnheer M, Schmid SM, et al. Evidence for the necessity to systematically assess micronutrient status prior to bariatric surgery. Obes Surg 2009; 19: 66-73. EL 3, SS.
  • 243
    Nicoletti CF, Lima TP, Donadelli SP, et al. New look at nutritional care for obese patient candidates for bariatric surgery. Surg Obes Relat Dis Epub 2011 Aug 28. EL 3, SS.
  • 244
    Toh SY, Zarshenas N, Jorgensen J. Prevalence of nutrient deficiencies in bariatric patients. Nutrition 2009; 25: 1150-6. EL 3, SS.
  • 245
    Alasfar F, Ben-Nakhi M, Khoursheed M, et al. Selenium is significantly depleted among morbidly obese female patients seeking bariatric surgery. Obes Surg 2011; 21: 1710-3. EL 3, SS.
  • 246
    Moizé V, Deulofeu R, Torres F, et al. Nutritional intake and prevalence of nutritional deficiencies prior to surgery in a Spanish morbidly obese population. Obes Surg 2011; 21: 1382-8. EL 3, SS.
  • 247
    Fish E, Beverstein G, Olson D, et al. Vitamin D status of morbidly obese bariatric surgery patients. J Surg Res 2010; 164: 198-202. EL 3, SS.
  • 248
    Signori C, Zalesin KC, Franklin B, et al. Effect of gastric bypass on vitamin D and secondary hyperparathyroidism. Obes Surg 2010; 20: 949-52. EL 3, SS.
  • 249
    Pereira S, Saboya C, Chaves G, et al. Class III obesity and its relationship with the nutritional status of vitamin A in pre- and postoperative gastric bypass. Obes Surg 2009; 19: 738-44. EL 3, SS.
  • 250
    de Luis DA, Pacheco D, Izaola O, et al. Zinc and copper serum levels of morbidly obese patients before and after biliopancreatic diversion: 4 years of follow-up. J Gastrointest Surg 2011; 15: 2178-81. EL 3, SS.
  • 251
    Botella Romero F, Milla Tobarra M, Alfaro Martínez JJ, et al. Bariatric surgery in duodenal switch procedure: weight changes and associated nutritional deficiencies. Endocrinol Nutr 2011; 58: 214-8. EL 3, SS.
  • 252
    Balsa JA, Botella-Carretero JI, Gómez-Martín JM, et al. Copper and zinc serum levels after derivative bariatric surgery: differences between Roux-en-Y gastric bypass and biliopancreatic diversion. Obes Surg 2011; 21: 744-50. EL 3, SS.
  • 253
    Aasheim ET, Björkman S, Søvik TT, et al. Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch. Am J Clin Nutr 2009; 90: 15-22. Erratum in: Am J Clin Nutr 2010; 91: 239-40. EL 1, RCT.
  • 254
    Carroll K. Obesity as a risk factor for certain types of cancer. Lipids 1998; 33: 1055-9. EL 4, NE review.
  • 255
    Bergstrom A, Pisani P, Tenet V, et al. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001; 91: 421-30. [Erratum, Int J Cancer 2001; 92: 927]. EL 3, SS meta-analysis of published epidemiological data.
  • 256
    Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001; 411: 390-5. EL 4, NE review.
  • 257
    Chow W-H, Blot WJ, Vaughan TL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998; 90: 150-5. EL 3, SS.
  • 258
    Vaughan TL, Davis S, Kristal A, Thomas DB. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 1995; 4: 85-92. EL 3, SS.
  • 259
    Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-38. EL 2, PCS.
  • 260
    Gagné DJ, Papasavas PK, Maalout M, et al. Obesity surgery and malignancy: our experience after 1500 cases. Surg Obes Relat Dis 2009; 5: 160-4. EL 3, SS.
  • 261
    Pilone V, Tramontano S, Formato A, et al. Role of bariatric surgery in early detection of renal cell carcinoma: report of two cases and review of the literature. Chir Ital 2008; 60: 703-9. EL 3, CCS.
  • 262
    Ashrafian H, Ahmed K, Rowland SP, et al. Metabolic surgery and cancer: protective effects of bariatric procedures. Cancer 2011; 117: 1788-199. EL 4, NE review.
  • 263
    Winfree LE, Henretta MS, Hallowell PT, et al. Pre-operative gynecologic evaluation of bariatric surgery patients: improving cancer detection in a high-risk population. J Am Coll Surg 2010; 211: 256-62. EL 3, SS.
  • 264
    Sarwer DB, Moore RH, Spitzer JC, et al. A pilot study investigating ther efficacy of postoperative dietary counseling to improve outcomes after bariatric surgery. Surg Obes Relat Dis 2012; 8: 561-8. EL 1, RCT.
  • 265
    Kulick D, Hark L, Deen D. The bariatric surgery patient: a growing role for registered dietitians. J Am Diet Assoc 2010; 110: 593-9. EL 4, NE position.
  • 266
    Ziegler O, Sirveaux MA, Brunaud L, et al. Medical follow up after bariatric surgery: nutritional and drug issues. General recommendations for the prevention and treatment of nutritional deficiencies. Diabetes Metab 2009; 35: 544-57. EL 4, NE consensus.
  • 267
    Faria SL. Dietary protein intake and bariatric surgery. Obes Surg 2011; 21: 1798-805. EL 4, NE review.
  • 268
    Raftopoulos I. Protein intake compliance with morbidly obese patients undergoing bariatric surgery and its effect on weight loss and biochemical parameters. Surg Obes Relat Dis 2011; 7: 733-42. EL 2, PCS.
  • 269
    Billy H, Okerson T. Changes in body composition following gastric bypass or gastric banding. AACE 21st Annual Scientific and Clinical Congress, May 23-27, 2012, Philadelphia; Abstract #1315. EL 3, SS.
  • 270
    Bavaresco M, Paganini S, Pereira Lima T, et al. Nutritional course of patients submitted to bariatric surgery. Obes Surg 2010; 20: 716-21. EL 2, PCS.
  • 271
    Andreu A, Moize V, Rodriguez L, et al. Protein intake, body composition, and protein status following bariatric surgery. Obes Surg 2010; 20: 1509-15. EL 2, PCS.
  • 272
    Moize VL, Pi-Sunyer X, Mochari H, et al. Nutritional pyramid for post-gastric bypass patients. Obes Surg 2010; 20: 1133-41. EL 4, NE review.
  • 273
    Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev 2010; 11: 41-50. EL 4, review.
  • 274
    Miller AD, Smith KM. Medication and nutrient administration considerations after bariatric surgery. Am J Health Syst Pharm 2006; 63: 1852-7. EL 4, review.
  • 275
    Donadelli SP, Junqueira-Franco MV, de Mattos Donadelli CA, et al. Daily vitamin supplementation and hypovitaminosis after obesity surgery. Nutrition 2012; 28: 391-6. EL 2, PCS.
  • 276
    Aills L, Blankenship J, Buffington C, et al. ASMBS Allied Health Nutritional Guidelines for the Surgical Weight Loss Patient Surgery for Obesity and Related Diseases 2008; S73-S108. EL 4, NE CPG.
  • 277
    Malone M. Recommended nutritional supplements for bariatric surgery patients. Ann Pharmacother 2008; 42: 1851-8. EL 4, NE review.
  • 278
    Munoz M, Botella-Romero F, Gomez-Ramirez S, et al. Iron deficiency and anemia in bariatric surgical patients: causes, diagnosis and proper management. Nutr Hosp 2009; 24: 640-54. EL 4, NE review.
  • 279
    Ledoux S, Coupaye M, Bogard C, et al. Determinants of hyperhomocysteinemia after gastric bypass surgery in obese subjects. Obes Surg 2011; 21: 78-86. EL 2, PCS.
  • 280
    Vieira C, Cosmo C, Lucena R. The importance of methylmalonic acid dosage on the assessment of patients with neurological manifestations following bariatric surgery. Obes Surg 2011; 21: 1971-4. EL 3, SCR.
  • 281
    Li K, Kaaks R, Linseisen J, et al. Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart 2012; 98: 920-5. EL 2, PCS.
  • 282
    Goldner WS, Stoner JA, Lyden E, et al. Finding the optimal dose of vitamin D following Roux-en-Y gastric bypass: a prospective, randomized pilot clinical trial. Obes Surg 2009; 19: 173-9. EL 1, RCT.
  • 283
    Holick MF, Binkley NC, Bischoff-Farrari HA, et al. Guidelines on vitamin D deficiency. J Clin Endocrinol Metab 2011; 96: 1911-30. EL 4, NE position.
  • 284
    Kondrup J, Rasmussen HH, Hamberg O, et al. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 2003; 22: 321-36. EL 3, SS.
  • 285
    Martindale RG, McClave SA, Vanek VW, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition: Executive Summary. Crit Care Med 2009; 37: 277-316. EL 4, NE CPG.
  • 286
    Singer P, Berger MM, Van den Berghe G, et al. ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr 2009; 28: 387-400. EL 4, NE CPG.
  • 287
    Heyland DK, Dhaliwal R, Drover JW, et al. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. J Parenter Enteral Nutr 2003; 27: 355-73. EL 4, NE CPG.
  • 288
    Martindale RG, DeLegge M, McClave S, et al. Nutrition delivery for obese ICU patients: delivery issues, lack of guidelines, and missed opportunities. J Parenter Enteral Nutr 2011; 35:( Suppl 1): 80S-7S. EL 4, NE review.
  • 289
    Morales MP, Miedema BW, Scott JS, et al. Management of postsurgical leaks in the bariatric patient. Gastrointest Endoscopy Clin N Am 2011; 21: 295-304. EL 4, NE review.
  • 290
    Segaran E. Symposium 7: Downsize me. Provision of nutritional support to those experiencing complications following bariatric surgery. Proceedings Nutr Soc 2010; 69: 536-42. EL 4, NE review.
  • 291
    Hamilton C, Dasari V, Shatnawei A, et al. Hypocaloric home parenteral nutrition and nutrition parameters in patients following bariatric surgery. Nutr Clin Pract 2011; 26: 577-82. EL 3, SS.
  • 292
    Schlienger J-L, Pradignac A, Luca F, et al. Medical management of diabetes after bariatric surgery. Diab Metab 2009; 35: 558-61. EL 4, NE review.
  • 293
    Joseph B, Genaw J, Carlin A, et al. Perioperative tight glycemic control: the challenge of bariatric surgery patients and the fear of hypoglycemic events. Permanente J 2007; 11: 36-9. EL 3, SS.
  • 294
    Aberle J, Reining F, Dannheim V, et al. Metformin after bariatric surgery—an acid problem. Exp Clin Endocrinol Diabetes 2012; 120: 152-3. EL 2, PCS.
  • 295
    Padwal RS, Gabr RQ, Sharma AM, et al. Effect of gastric bypass surgery on the absorption and bioavailability of metformin. Diabetes Care 2011; 34: 1295-300. EL 2, NRCT.
  • 296
    Rothkopf MM, Bilof ML, Haverstick LP, et al. Synergistic weight loss and diabetes resolution with exenatide administration after laparoscopic gastric banding. Surg Obes Relat Dis 2009; 5: 128-31. EL 3, SCR.
  • 297
    Chiumello D, Chevallard G, Gregoretti C. Non-invasive ventilation in postoperative patients: a systematic review Intensive Care Med 2011; 37: 918-29. EL 4, NE review.
  • 298
    Gupta PK, Gupta H, Kaushik M, et al. Predictors of pulmonary complications after bariatric surgery. Surg Obes Relat Dis. EL 3, SS.
  • 299
    Ramirez A, Lalor PF, Szomstein S, et al. Continuous positive airway pressure in immediate postoperative period after laparoscopic Roux- en-Y gastric bypass: is it safe? Surg Obes Relat Dis 2009; 5: 544-6. EL 3, SS.
  • 300
    Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 381S-453S. EL 4, NE CPG.
  • 301
    Magee CJ, Barry J, Javed S, et al. Extended thromboprophylaxis reduces incidence of postoperative venous thromboembolism in laparoscopic bariatric surgery. Surg Obes Relat Dis 2010; 6: 322-5. EL 3, SS.
  • 302
    Raftopoulos I, Martindale C, Cronin A, et al. The effect of extended post-discharge chemical thromboprophylaxis on venous thromboembolism rates after bariatric surgery: a prospective comparison trial. Surg Endosc 2008; 22: 2384-91. EL 2, PCS.
  • 303
    Winegar DA, Sherif B, Pate V, et al. Venous thromboembolism after bariatric surgery performed by Bariatric Surgery Center of Excellence Participants: analysis of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis 2011; 7: 181-8. EL 3, SS.
  • 304
    Birkmeyer NJ, Share D, Baser O, et al. Preoperative placement of inferior vena cava filters and outcomes after gastric bypass surgery. Ann Surg 2010; 252: 313-8. EL 3, SS.
  • 305
    de Aretxabala X, Leon J, Wiedmaier G, et al. Gastric leak after sleeve gastrectomy: analysis of its management. Obes Surg 2011; 21: 1232-7. EL 3, CCS (small sample size; N=9).
  • 306
    Bellanger DE, Greenway FL. Laparoscopic sleeve gastrectomy, 529 cases without a leak: short-term results and technical considerations. Obes Surg 2011; 21: 146-50. EL 3, SS.
  • 307
    Aurora AR, Khaitan L. Saber AA. Sleeve gastrectomy and the risk of leak: a systematic analysis of 4,888 patients. Surg Endosc 2012; 26: 1509-15. EL 2, MNRCT.
  • 308
    Triantafyllidis G, Lazoura O, Sioka E, et al. Anatomy and complications following laparoscopic sleeve gastrectomy: radiological evaluation and imaging pitfalls. Obes Surg 2011; 21: 473-8. EL 3, CCS.
  • 309
    Marquez MF, Ayza MF, Lozano RB, et al. Gastric leak after laparoscopic sleeve gastrectomy. Obes Surg 2010; 20: 1306-11. EL 4, NE review.
  • 310
    Gagner M. Leaks after sleeve gastrectomy are associated with smaller bougies: prevention and treatment strategies. Surg Laparosc Endosc Percutan Tech 2010; 20: 166-9. EL 4, NE opinion.
  • 311
    The ASMBS Clinical Issues Committee. ASMBS Guideline on the prevention and detection of gastrointestinal leak after gastric bypass including the role of imaging and surgical exploration. Surg Obes Relat Dis 2009; 5: 293-6. EL 4, NE, position.
  • 312
    Warschkow R, Tarantino I, Folie P, et al. C-reactive protein 2 days after laparoscopic gastric bypass surgery reliably indicates leaks and moderately predicts morbidity. J Gastrointest Surg 2012; 16: 1128-35. EL 3, SS.
  • 313
    Lyass S, Khalili TM, Cunneen S, et al. Radiological studies after laparoscopic Roux-en-Y gastric bypass: routine or selective? Am Surg 2004; 70: 918-21. EL 3, SS.
  • 314
    Carussi LR, Turner MA, Conklin RC, et al. Roux-en-Y gastric bypass surgery for morbid obesity: evaluation of postoperative extraluminal leaks with upper gastrointestinal series. Radiology 2006; 238: 119-27. EL 3, SS.
  • 315
    Mognol P, Vignes SM, Chosidow D, et al. Rhabdomyolysis after pararoscopic bariatric surgery. Obes Surg 2004; 14: 91-4. EL 2, PCS.
  • 316
    Wool DB, Lemmens HJ, Brodsky JB, et al. Intraoperative fluid replacement and postoperative creatine phosphokinase levels in laparoscopic bariatric patients. Obes Surg 2010; 20: 698-701. EL 1, RCT (single-blinded).
  • 317
    Youssef T, Abd-Elaal I, Zakaria G, et al. Bariatric surgery: Rhabdomyolysis after open Roux-en-Y gastric bypass: a prospective study. Int J Surg 2010; 8: 484-8. EL 2, PCS.
  • 318
    El Chaar M, McDeavitt K, Richardson S, et al. Does patient compliance with preoperative bariatric office visits affect postoperative excess weight loss? Surg Obes Relat Dis 2011; 7: 743-8. EL 3, SS.
  • 319
    Shen R, Dugay G, Rajaram K, et al. Impact of patient follow-up on weight loss after bariatric surgery. Obes Surg 2004; 14: 514-9. EL 3, SS.
  • 320
    Dixon JB, Laurie CP, Anderson ML, et al. Motivation, readiness to change, and weight loss following adjustable gastric band surgery. Obesity (Silver Spring) 2009; 17: 698-705. EL 3, SS.
  • 321
    Weichman K, Ren C, Kurian M, et al. The effectiveness of adjustable gastric banding: a retrospective 6-year U.S. follow-up study. Surg Endosc 2011; 25: 397-403. EL 3, SS.
  • 322
    Kofman MD, Lent MR, Swencionis C. Maladaptive eating patterns, quality of life, and weight outcomes following gastric bypass: results of an internet survey. Obesity 2010; 18: 1938-43. EL 3, SS.
  • 323
    Rutledge T, Groez LM, Savu M. Psychiatric factors and weight loss patterns following gastric bypass surgery in a veteran population. Obes Surg 2011; 21: 29-35. EL 2, PCS.
  • 324
    Odom J, Zalesin KC, Washington TL. Behavioral Predictors of Weight Regain after Bariatric Surgery 2010; 20: 349-56. EL 3, SS.
  • 325
    Faria SL, de Olivera Kelly E, Lins RD. Nutritional Management of Weight Regain After Bariatric Surgery. Obes Surg 2010; 20: 135-9. EL 2, PCS.
  • 326
    Langer FB, Bohdjalian A, Shakeri-Manesch S. Inadequate Weight Loss vs Secondary Weight Regain: Laparoscopic Conversion from Gastric Banding to Roux-en-Y Gastric Bypass. Obes Surg 2008; 18: 1381-6. EL 2, PCS.
  • 327
    Yimcharoen P, Heneghan HM, Singh M. Endoscopic findings and outcomes of revisional procedures for patients with weight recidivism after gastric bypass. Surg Endosc 2011; 25: 3345-52. EL 3, SS.
  • 328
    Kellogg TA. Revisional Bariatric Surgery. Surg Clin N Am 2011; 91: 1353-71. EL 4, NE review.
  • 329
    Ziegler O, Sirveaux MA, Brunaud L, et al. Medical followup after bariatric surgery: nutritional and drug issues. Diab Metab 2009; 35: 544-57. EL 4, NE review.
  • 330
    Koch TR, Finelli FC. Postoperative metabolic and nutritional complications of bariatric surgery. Gastroenterol Clin N Am 2010; 39: 109-24. EL 4, NE review.
  • 331
    Ceppa EP, Ceppa DP, Omotosho PA, Dickerson JA 2nd, Park CW, Portenier DD. Algorithm to diagnose etiology of hypoglycemia after Roux-en-Y gastric bypass for morbid obesity: case series and review of the literature. Surg Obes Relat Dis 2012; 8: 641-7. EL 3, CCS.
  • 332
    Cui Y, Elahi D, Andersen DK. Advances in the etiology and management of hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. J Gastrointest Surg 2011; 15: 1879-88. EL 3, CCS.
  • 333
    Bernard B, Kline GA, Service FJ. Hypoglycemia following upper gastrointestinal surgery: case report and review of the literature. BMC Gastroenterology 2010; 10: 77-80. EL 3, SCR.
  • 334
    Spanakis E, Gragnoli C. Successful medical management of status post-Roux-en-Y-gastric-bypass hyperinsulinemic hypoglycemia. Obes Surg 2009; 19: 1333-4. EL 3, SCR.
  • 335
    Moreira RO, Moreira RBM, Machado NAM, et al. Postprandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose. Obes Surg 2008; 18: 1618-21. EL 3, SCR.
  • 336
    Z'graggen K, Guweidhi A, Steffen R, et al. Severe recurrent hypoglycemia after gastric bypass surgery. Obes Surg 2008; 18: 981-8. EL 2, PCS (small study; N=12).
  • 337
    Abellan P, Camara R, Merino-Torres JF, et al. Severe hypoglycemia after gastric bypass surgery for morbid obesity. Diab Res Clin Pract 2008; 79: e7-9. EL 3, SCR.
  • 338
    Wouters EJ, Larsen JK, Zijlstra H, et al. Physical activity after surgery for severe obesity: the role of exercise cognitions. Obes Surg 2011; 21: 1894-9. EL 2, PCS.
  • 339
    Josbeno DA, Kalarchian M, Sparto PJ, et al. Physical activity and physical function in individuals post-bariatric surgery. Obes Surg 2011; 21: 1243-9. EL 2, PCS.
  • 340
    Livhits M, Mercado C, Yermilov I, et al. Behavioral factors associated with successful weight loss after gastric bypass. Am Surg 2010; 76: 1139-42. EL 3, SS.
  • 341
    Hatoum IJ, Stein HK, Merrifield BF, et al. Capacity for physical activity predicts weight loss after Roux-en-Y gastric bypass. Obesity 2008; 17: 92-9. EL 2, PCS.
  • 342
    Stegen S, Derave W, Calders P, et al. Physical fitness in morbidly obese patients: effet of gastric bypass surgery and exercise training. Obes Surg 2011; 21: 61-70. EL 2, NRCT.
  • 343
    Castello V, Simoes P, Bassi D, et al. Impact of aerobic exercise training on heart rate variability and functional capacity in obese women after gastric bypass surgery. Obes Surg 2011; 21: 1739-49. EL 1, RCT (findings limited by generalizability and relevance of dysautonomia on overall outcomes).
  • 344
    Shah M, Snell PG, Rao S, et al. High-volume exercise program in obese bariatric surgery patients: a randomized, controlled trial. Obesity 2011; 19: 1826-34. EL 1, RCT (findings limited by methodological flaws in exercise program and individual dietary counseling rather than group counseling).
  • 345
    Egberts K, Brown WA, Brennan L, et al. Does exercise improve weight loss after bariatric surgery? A systematic review. Obes Surg 2012; 22: 335-41. EL 2, MNRCT.
  • 346
    Livhits M, Mercado C, Yermilov I, et al. Exercise following bariatric surgery: systematic review. Obes Surg 2010; 20: 657-65. EL 2, MNRCT.
  • 347
    Jacobi D, Ciangura C, Couet C, et al. Physical activity and weight loss following bariatric surgery. Obes Rev 2011; 12: 366-77. EL 2, MNRCT.
  • 348
    Livhits M, Mercado C, Yermilov I, et al. Is social support associated with greater weight loss after bariatric surgery?: a systematic review. Obes Reviews 2011; 12: 142-8. EL 2, MNRCT.
  • 349
    Orth WS, Madan AK, Taddeucci RJ, et al. Support group meeting attendance is associated with better weight loss. Obes Surg 2008; 18: 391-4. EL 3, SS.
  • 350
    Song Z, Reinhardt K, Busdon M, et al. Association between support group attendance and weight loss after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2008; 4: 100-3. EL 3, SS.
  • 351
    Elakkary E, Elhorr A, Aziz F, et al. Do support groups play a role in weight loss after laparoscopic adjustable gastric banding? Obes Surg 2006; 16: 331-4. EL 3, SS.
  • 352
    Kaiser KA, Franks SF, Smith AB. Positive relationship between support group attendance and one-year postoperative weight loss in gastric banding patients. Surg Obes Relat Dis 2011; 7: 89-93. EL 3, SS.
  • 353
    Gómez JM, Vilarrasa N, Masdevall C, et al. Regulation of bone mineral density in morbidly obese women: a cross-sectional study in two cohorts before and after by-pass surgery. Obes Surg 2009; 19: 345-50. EL 3, CSS.
  • 354
    Scibora LM, Ikramuddin S, Buchwald H, et al. Examining the link between bariatric surgery, bone loss, and osteoporosis: a review of bone density studies. Obes Surg 2012; 22: 654-67. EL 4, NE review.
  • 355
    Williams SE. Metabolic bone disease in bariatric surgery patients. J Obes 2011; 2011: 634614. EL 4, NE review.
  • 356
    Kumar R, Lieske JC, Collazo-Clavell ML, et al. Fat malabsorption and increased oxalate absorption are common after roux-en-Y gastric bypass surgery. Surgery 2011; 149: 654-61. EL 2, PCS.
  • 357
    Sakhaee K, Griffith C, Pak CY. Biochemical control of bone loss and stone-forming propensity by potassium-calcium citrate after bariatric surgery. Surg Obes Relat Dis 2012; 8: 67-72. EL 1, RCT (2-phase, crossover, blinding not mentioned).
  • 358
    Okombo J, Liebman M. Probiotic-induced reduction in gastrointestinal oxalate absorption in healthy subjects. Urol Res 2010; 38: 169-78. EL 2, PCS.
  • 359
    Woodward GA, Encarnacion B, Downey JR, et al. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg 2009; 13: 1198-204. EL 1, RCT (N = 41, double-blinded).
  • 360
    Butler C, Vidal-Alaball J, Cannings-John R, et al. Oral vitamin b12 versus intramuscular vitamin B12 for b12 deficiency: a systematic review of randomized controlled trials. Fam Pract 2006; 23: 279-85. EL 1, MRCT.
  • 361
    Salle A, Demarsy D, Poirier AL, et al. Zinc deficiency: a frequent and underestimated complication after bariatric surgery. Obes Surg 2010; 20: 1660-70. EL 3, SS.
  • 362
    Rosa FT, de Oliveira-Penaforte FR, de Arruda Leme I, et al. Altered plasma response to zinc and iron tolerance test after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2011; 7: 309-14. EL 2, PCS.
  • 363
    Lakhani SV, Shah HN, Alexander K, et al. Small intestinal bacterial overgrowth and thiamine deficiency after Roux-en-Y gastric bypass surgery in obese patients. Nutr Res 2008; 28: 293-8. EL 3, SS.
  • 364
    Perna M, Baker M, Byrne TK, et al. Statins and the bariatric patient: characterization and perioperative effects of statin therapy in the gastric bypass patient. Am Surg 2011; 77: 44-7. EL 3, SS.
  • 365
    Ahmed AR, Rickards G, Coniglio D, et al. Laparoscopic Roux-en-Y gastric bypass and its early effect on blood pressure. Obes Surg 2009; 19: 845-9. EL 2, PCS.
  • 366
    Batsis JA, Romero-Corral A, Collazo-Clavell ML, et al. Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc 2008; 83: 897-907. EL 2, PCS (non-matched).
  • 367
    Delling L, Karason K, Olbers T, et al. Feasibility of bariatric surgery as a strategy for secondary prevention in cardiovascular disease: a report from the Swedish obese subjects trial. J Obes 2010;2010. pii: 102341. EL 2, PCS.
  • 368
    Straznicky N, Grassi G, Esler M, et al. European Society of Hypertension Working Group on Obesity antihypertensive effects of weight loss: myth or reality? J Hypertens 2010; 28: 637-43. EL 4, NE consensus.
  • 369
    Straznicky NE, Grima MT, Eikelis N, et al. The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components. J Clin Endocrinol Metab 2011; 96: E503-8. EL 2, PCS.
  • 370
    Potoczna N, Harfmann S, Steffen R, et al. Bowel habits after bariatric surgery. Obesity Surg 2008; 18: 1287-96. EL 3, SS.
  • 371
    Felix EL, Kettelle J, Mobley E, et al. Perforated marginal ulcers after laparoscopic gastric bypass. Surg Endosc 2008; 22: 2128-32. EL 3, SS.
  • 372
    Sasse KC, Ganser J, Kozar M, et al. Seven cases of gastric perforation in Roux-en-Y gastric bypass patients: what lessons can we learn? Obes Surg 2008; 18: 530-4. EL 3, SS.
  • 373
    Ryou M, Mogabgab O, Lautz DB, et al. Endoscopic foreign body removal for treatment of chronic abdominal pain in patients after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2010; 6: 526-31. EL 3, SS.
  • 374
    Deylgat BD, Hondt M, Pottel H, et al. Indications, safety, and feasibility of conversion of failed bariatric surgery to Roux-en-Y gastric bypass: a retrospective comparative study with primary laparoscopic Roux-en-Y gastric bypass. Surg Endosc 2012; 26: 1997-2002. EL 3, SS (56 revisional procedures for RYGB).
  • 375
    Morales MP, Wheeler AA, Ramaswamy A, et al. Laparoscopic revisional surgery after Roux-en-Y gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis 2010; 6: 485-90. EL 3, SS (23 revisional procedures for RYGB).
  • 376
    Salimath J, Rosenthal RJ, Szomstein S. Laparoscopic remnant gastrectomy as a novel approach for treatment of gastrogastric fistula. Surg Endosc 2009; 23: 2591-5. EL 3, SS (22 revisional procedures for RYGB).
  • 377
    Tucker ON, Escalante-Tattersfield T, Szomstein S, et al. Laparoscopic management of chronic gastric pouch fistula after laparoscopic gastric bypass. Surg Obes Relat Dis 2009; 5: 278-9. EL 3, SCR.
  • 378
    Madan AK, Dhawan N, Ternovits CA, et al. Laparoscopic repair of a staple-line disruption after an open uncut Roux-en-Y gastric bypass. Obes Surg 2008; 18: 340-4. EL 3, SCR.
  • 379
    Hil MW, Clarke NE, Hopkins GH. Gastrogastric herniation: an unusual complication following greater curve plication for the treatment of morbid obesity. Ann R Coll Surg Engl 2012; 94: e76-8. EL 3, SCR.
  • 380
    Flicker MS. Lautz, Thompson CC. Endoscopic management of gastrogastric fistulae does not increase complications at bariatric revision surgery. J Gastrointest Surg 2011; 15: 1736-42. EL 3, SS.
  • 381
    Bhardwaj A, Cooney RN, Wehrman A, et al. Endoscopic repair of small symptomatic gastrogastric fistulas after gastric bypass surgery: a single center experience. Obes Surg 2010; 20: 1090-5. EL 3, SS.
  • 382
    Spaun GO, Marinec DV, Kennedy TJ, et al. Endoscopic closure of gastrogastric fistulas by using a tissue apposition system (with videos). Gastrointest Endosc 2010; 71: 606-11. EL 3, CCS.
  • 383
    Fernandez-Esparrach G, Lautz DB, Thompson CC. Endoscopic repair of gastrogastric fistula after Roux-en-Y gastric bypass: a less-invasive approach. Surg Obes Relat Dis 2010; 6: 282-8. EL 3, SCR.
  • 384
    deWolfe MA, Bower CE. Using the StomaphyXTM endoplicator to treat a gastric bypass complication. JSLS 2011; 15: 109-13. EL 3, SCR.
  • 385
    Kothari SN. Bariatric surgery and postoperative imaging. Surg Clin N Am 2011; 91: 155-72. EL 4, review.
  • 386
    Taratino I, Warschkow R, Steffen T, et al. Is routine cholecystectomy justified in severely obese patients undergoing a laparoscopic Roux-en-Y gastric bypass procedure? A comparative cohort study. Obes Surg 2011; 21: 1870-8. EL 2, PCS.
  • 387
    Uy MC, Talingdan-Te MC, Espinosa WZ, et al. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis. Obes Surg 2008; 18: 1532-8. EL 1, MRCT.
  • 388
    Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 2011; 364: 22-32. EL 1, RCT (no bariatric surgery patients).
  • 389
    Datta T, Eid G, Nahmias N, et al. Management of ventral hernias during laparoscopic gastric bypass. Surg Obes Relat Dis 2008; 4: 754-7. EL 3, SS.
  • 390
    Praveen Raj P, Senthiinathan P, Kumaravel R, et al. Concomitant laparoscopic ventral hernia mesh repair and bariatric surgery: a retrospective study from a tertiary care center. Obes Surg 2012; 22: 685-9. EL 3, SS.
  • 391
    Husain S, Ahmed AR, Johnson J, et al. Small-bowel obstruction after laparoscopic Rouxen-Y gastric bypass: etiology, diagnosis, and management. Arch Surg 2007; 142: 988-93. EL 3, SS.
  • 392
    van der Beek ES, Te Riele W, Specken TF, et al. The impact of reconstructive procedures following bariatric surgery on patient well-being and quality of life. Obes Surg 2010; 20: 36-41. EL 3, SS.
  • 393
    Breiting LB, Lock-Andersen J, Matzen SH, et al. Increased morbidity in patients undergoing abdominoplasty after laparoscopic gastric bypass. Dan Med Bull 2011; 58: A4251. EL 3, SS.
  • 394
    O'Brien JA, Broderick GB, Hurwitz ZM, et al. Fleur-de-lis panniculectomy after bariatric surgery: our experience. Ann Plast Surg 2012; 68: 74-8. EL 3, SS.
  • 395
    Moya AP, Sharma D. A modified technique combining vertical and high lateral incisions for abdominal-to-hip contouring following massive weight loss in persistently obese patient. J Plast Reconstr Aesthet Surg 2009; 62: 56-64. EL 3, SS.
  • 396
    Vico PG, De Vooght A, Nokerman B. Circumferential body contouring in bariatric and non-bariatric patient. J Plast Reconstr Aesthet Surg 2010; 63: 814-9. EL 3, SS.
  • 397
    Hamdi M, Van Landuyt K, Blondeel P, et al. Autologous breast augmentation with the lateral intercostal artery perforator flap in massive weight loss patients. J Plast Reconstr Aesthet Surg 2009; 62: 65-70. EL 3, SS.
  • 398
    Van der Beek ES, van der Molen AM, van Ramshorst B. Complications after body contouring surgery in post-bariatric patients: the importance of a stable weight close to normal. Obes Facts 2011; 4: 61-6. EL 3, SS.
  • 399
    Dorman RB, Miller CJ, Leslie DB, et al. Risk for hospital readmission following bariatric surgery. PLoS One 2012; 7: e32506. EL 2, PCS.
  • 400
    Hong B, Stanley E, Reinhardt S, et al. Factors associated with readmission after laparoscopic gastric bypass surgery. Surg Obes Relat Dis 2011; 8: 691-5. EL 3, SS.
  • 401
    Kellogg TA. Revisional bariatric surgery. Surg Clin N Am 2011; 91: 1353-71. EL 4, NE review.
  • 402
    Stegtenhorst BR, van der Harst E, Demirkiran A, et al. Effect of primary versus revisional Roux-en-Y gastric bypass: inferior weight loss of revisional surgery after gastric banding. Surg Obes Relat Dis Epub 2012 Mar 7. EL 3, SS.
  • 403
    Brolin RE, Asad M. Rationale for reversal of failed bariatric operations. Surg Obes Relat Dis 2009; 5: 673-6. EL 3, SS.